サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1487514

凝固検査市場：世界の産業分析、規模、シェア、成長、動向、予測、2024-2034年

Coagulation Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034

出版日
ページ情報
英文 177 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
凝固検査市場：世界の産業分析、規模、シェア、成長、動向、予測、2024-2034年
出版日: 2024年04月22日
発行: Transparency Market Research
ページ情報: 英文 177 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

凝固検査市場- 調査範囲

TMRの世界の凝固検査市場に関する調査レポートは、2024年から2034年までの予測期間における市場の指標について貴重な洞察を得るために、過去だけでなく現在の成長動向と機会についても調査しています。2024年を基準年、2034年を予測年として、2018年から2034年までの世界の凝固検査市場の収益と予測を提供しています。また、2024年から2034年までの世界の凝固検査市場の複合年間成長率（CAGR %）も掲載しています。

本レポートは広範な調査を経て作成されました。1次調査では、主要オピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施しました。2次調査では、主要企業の製品資料、年次報告書、プレスリリース、関連文書などを参照し、凝固検査市場を理解しました。

市場スナップショット
2023年の市場規模 34億米ドル
2034年の市場価値 65億米ドル
CAGR 6%

本レポートでは、世界の凝固検査市場の競合情勢について掘り下げています。世界の凝固検査市場で事業を展開する主要企業が特定され、各企業がさまざまな属性でプロファイルされています。企業概要、財務状況、最近の動向、SWOTは、本レポートで紹介されている世界の凝固検査市場におけるプレイヤーの属性です。

目次

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー：世界市場

第4章 市場概要

  • イントロダクション
  • 市場概要
  • 市場力学
  • 市場分析と予測、2020-2034年

第5章 主要洞察

  • パイプライン分析
  • 主要製品・ブランド分析
  • 主要M&A
  • COVID-19パンデミックの産業への影響

第6章 世界市場分析と予測：製品タイプ別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測：製品タイプ別、2020年～2034年
    • 器具
    • 消耗品
  • 市場魅力度分析：製品タイプ別

第7章 世界市場分析・予測：検査タイプ別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測：検査タイプ別、2020年～2034年
    • プロトロンビン時間（PT）
    • 活性化部分トロンボプラスチン凝固時間（APTT）
    • トロンビン時間（TT）
    • 活性化凝固時間（ACT）
    • その他
  • 市場魅力度分析：検査タイプ別

第8章 世界市場分析・予測：エンドユーザー別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測：エンドユーザー別、2020年～2034年
    • 病院・クリニック
    • 診断研究所
    • 在宅医療
    • その他
  • 市場魅力度分析：エンドユーザー別

第9章 世界市場分析・予測：地域別

  • 主な調査結果
  • 市場金額予測：地域別, 2020-2034
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場魅力度分析：地域別

第10章 北米市場の分析と予測

第11章 欧州市場の分析と予測

第12章 アジア太平洋市場の分析と予測

第13章 ラテンアメリカ市場の分析と展望

第14章 中東・アフリカ市場の分析と展望

第15章 競合情勢

  • 市場競合マトリックス（企業階層別・企業規模別）
  • 市場シェア分析：企業別（2023年）
  • 企業プロファイル
    • F. Hoffmann-La Roche Ltd.
    • Abbott
    • Siemens Healthineers
    • Sysmex Corporation
    • Universal Biosensors, Inc.
    • HemoSonics, LLC
    • Thermo Fisher Scientific Inc.
    • Randox Laboratories Ltd.
    • Horiba, Ltd.
    • Agappe Diagnostics Ltd.
    • Medtronic
    • Helena Laboratories, Inc.
図表

List of Tables

  • Table 01: Global Coagulation Testing Market Size (US$ Mn) Forecast, by Product Type, 2020-2034
  • Table 02: Global Coagulation Testing Market Size (US$ Mn) Forecast, by Test Type, 2020-2034
  • Table 03: Global Coagulation Testing Market Size (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 04: Global Coagulation Testing Market Size (US$ Mn) Forecast, by Region, 2020-2034
  • Table 05: North America Coagulation Testing Market Size (US$ Mn) Forecast, by Country, 2020-2034
  • Table 06: North America Coagulation Testing Market Size (US$ Mn) Forecast, by Product Type, 2020-2034
  • Table 07: North America Coagulation Testing Market Size (US$ Mn) Forecast, by Test Type, 2020-2034
  • Table 08: North America Coagulation Testing Market Size (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 09: Europe Coagulation Testing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 10: Europe Coagulation Testing Market Size (US$ Mn) Forecast, by Product Type, 2020-2034
  • Table 11: Europe Coagulation Testing Market Size (US$ Mn) Forecast, by Test Type, 2020-2034
  • Table 12: Europe Coagulation Testing Market Size (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 13: Asia Pacific Coagulation Testing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 14: Asia Pacific Coagulation Testing Market Size (US$ Mn) Forecast, by Product Type, 2020-2034
  • Table 15: Asia Pacific Coagulation Testing Market Size (US$ Mn) Forecast, by Test Type, 2020-2034
  • Table 16: Asia Pacific Coagulation Testing Market Size (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 17: Latin America Coagulation Testing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 18: Latin America Coagulation Testing Market Size (US$ Mn) Forecast, by Product Type, 2020-2034
  • Table 19: Latin America Coagulation Testing Market Size (US$ Mn) Forecast, by Test Type, 2020-2034
  • Table 20: Latin America Coagulation Testing Market Size (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 21: Middle East & Africa Coagulation Testing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 22: Middle East & Africa Coagulation Testing Market Size (US$ Mn) Forecast, by Product Type, 2020-2034
  • Table 23: Middle East & Africa Coagulation Testing Market Size (US$ Mn) Forecast, by Test Type, 2020-2034
  • Table 24: Middle East & Africa Coagulation Testing Market Size (US$ Mn) Forecast, by End-user, 2020-2034

List of Figures

  • Figure 01: Global Coagulation Testing Market Size (US$ Mn) and Distribution (%), by Region, 2023 and 2034
  • Figure 02: Global Coagulation Testing Market Revenue (US$ Mn), by Product Type, 2023
  • Figure 03: Global Coagulation Testing Market Value Share, by Product Type, 2023
  • Figure 04: Global Coagulation Testing Market Revenue (US$ Mn), by Test Type, 2023
  • Figure 05: Global Coagulation Testing Market Value Share, by Test Type, 2023
  • Figure 06: Global Coagulation Testing Market Revenue (US$ Mn), by End-user, 2023
  • Figure 07: Global Coagulation Testing Market Value Share, by End-user, 2023
  • Figure 08: Global Coagulation Testing Market Value Share, by Region, 2023
  • Figure 09: Global Coagulation Testing Market Value (US$ Mn) Forecast, 2020-2034
  • Figure 10: Global Coagulation Testing Market Value Share Analysis, by Product Type, 2023 and 2034
  • Figure 11: Global Coagulation Testing Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 12: Global Coagulation Testing Market Value Share Analysis, by Test Type, 2023 and 2034
  • Figure 13: Global Coagulation Testing Market Attractiveness Analysis, by Test Type, 2024-2034
  • Figure 14: Global Coagulation Testing Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 15: Global Coagulation Testing Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 16: Global Coagulation Testing Market Value Share Analysis, by Region, 2023 and 2034
  • Figure 17: Global Coagulation Testing Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 18: North America Coagulation Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 19: North America Coagulation Testing Market Attractiveness Analysis, by Country, 2024-2034
  • Figure 20: North America Coagulation Testing Market Value Share Analysis, by Country, 2023 and 2034
  • Figure 21: North America Coagulation Testing Market Value Share Analysis, by Product Type, 2023 and 2034
  • Figure 22: North America Coagulation Testing Market Value Share Analysis, by Test Type, 2023 and 2034
  • Figure 23: North America Coagulation Testing Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 24: North America Coagulation Testing Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 25: North America Coagulation Testing Market Attractiveness Analysis, by Test Type, 2024-2034
  • Figure 26: North America Coagulation Testing Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 27: Europe Coagulation Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 28: Europe Coagulation Testing Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 29: Europe Coagulation Testing Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 30: Europe Coagulation Testing Market Value Share Analysis, by Product Type, 2023 and 2034
  • Figure 31: Europe Coagulation Testing Market Value Share Analysis, by Test Type, 2023 and 2034
  • Figure 32: Europe Coagulation Testing Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 33: Europe Coagulation Testing Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 34: Europe Coagulation Testing Market Attractiveness Analysis, by Test Type, 2024-2034
  • Figure 35: Europe Coagulation Testing Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 36: Asia Pacific Coagulation Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 37: Asia Pacific Coagulation Testing Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 38: Asia Pacific Coagulation Testing Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 39: Asia Pacific Coagulation Testing Market Value Share Analysis, by Product Type, 2023 and 2034
  • Figure 40: Asia Pacific Coagulation Testing Market Value Share Analysis, by Test Type, 2023 and 2034
  • Figure 41: Asia Pacific Coagulation Testing Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 42: Asia Pacific Coagulation Testing Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 43: Asia Pacific Coagulation Testing Market Attractiveness Analysis, by Test Type, 2024-2034
  • Figure 44: Asia Pacific Coagulation Testing Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 45: Latin America Coagulation Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 46: Latin America Coagulation Testing Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 47: Latin America Coagulation Testing Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 48: Latin America Coagulation Testing Market Value Share Analysis, by Product Type, 2023 and 2034
  • Figure 49: Latin America Coagulation Testing Market Value Share Analysis, by Test Type, 2023 and 2034
  • Figure 50: Latin America Coagulation Testing Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 51: Latin America Coagulation Testing Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 52: Latin America Coagulation Testing Market Attractiveness Analysis, by Test Type, 2024-2034
  • Figure 53: Latin America Coagulation Testing Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 54: Middle East & Africa Coagulation Testing Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 55: Middle East & Africa Coagulation Testing Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 56: Middle East & Africa Coagulation Testing Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 57: Middle East & Africa Coagulation Testing Market Value Share Analysis, by Product Type, 2023 and 2034
  • Figure 58: Middle East & Africa Coagulation Testing Market Value Share Analysis, by Test Type, 2023 and 2034
  • Figure 59: Middle East & Africa Coagulation Testing Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 60: Middle East & Africa Coagulation Testing Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 61: Middle East & Africa Coagulation Testing Market Attractiveness Analysis, by Test Type, 2024-2034
  • Figure 62: Middle East & Africa Coagulation Testing Market Attractiveness Analysis, by End-user, 2024-2034
目次
Product Code: TMRGL14168

Coagulation Testing Market - Scope of Report

TMR's report on the global coagulation testing market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global coagulation testing market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global coagulation testing market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the coagulation testing market.

Market Snapshot
Market Value in 2023US$ 3.4 Bn
Market Value in 2034US$ 6.5 Bn
CAGR6%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global coagulation testing market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global coagulation testing market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global coagulation testing market.

The report delves into the competitive landscape of the global coagulation testing market. Key players operating in the global coagulation testing market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global coagulation testing market profiled in this report.

Key Questions Answered in Global coagulation testing Market Report:

  • What is the sales/revenue generated by coagulation testing across all regions during the forecast period?
  • What are the opportunities in the global coagulation testing market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Coagulation Testing Market - Research Objectives and Research Approach

The comprehensive report on the global coagulation testing market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global coagulation testing market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global coagulation testing market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Coagulation Testing Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution/Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Coagulation Testing Market Analysis and Forecast, 2020-2034

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Product /Brand Analysis
  • 5.3. Key Mergers & Acquisitions
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global Coagulation Testing Market Analysis and Forecast, by Product Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Product Type, 2020-2034
    • 6.3.1. Instruments
    • 6.3.2. Consumables
  • 6.4. Market Attractiveness Analysis, by Product Type

7. Global Coagulation Testing Market Analysis and Forecast, by Test Type

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Test Type, 2020-2034
    • 7.3.1. Prothrombin Time (PT)
    • 7.3.2. Activated Partial Thromboplastin Clotting Time (APTT)
    • 7.3.3. Thrombin Time (TT)
    • 7.3.4. Activated Clotting Time (ACT)
    • 7.3.5. Others
  • 7.4. Market Attractiveness Analysis, by Test Type

8. Global Coagulation Testing Market Analysis and Forecast, by End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by End-user, 2020-2034
    • 8.3.1. Hospitals and Clinics
    • 8.3.2. Diagnostic Laboratories
    • 8.3.3. Home Care Settings
    • 8.3.4. Others
  • 8.4. Market Attractiveness Analysis, by End-user

9. Global Coagulation Testing Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region, 2020-2034
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, by Region

10. North America Coagulation Testing Market Analysis and Forecast

  • 10.1. Introduction
  • 10.2. Key Findings
  • 10.3. Market Value Forecast, by Product Type, 2020-2034
    • 10.3.1. Instruments
    • 10.3.2. Consumables
  • 10.4. Market Value Forecast, by Test Type, 2020-2034
    • 10.4.1. Prothrombin Time (PT)
    • 10.4.2. Activated Partial Thromboplastin Clotting Time (APTT)
    • 10.4.3. Thrombin Time (TT)
    • 10.4.4. Activated Clotting Time (ACT)
    • 10.4.5. Others
  • 10.5. Market Value Forecast, by End-user, 2020-2034
    • 10.5.1. Hospitals and Clinics
    • 10.5.2. Diagnostic Laboratories
    • 10.5.3. Home Care Settings
    • 10.5.4. Others
  • 10.6. Market Value Forecast, by Country, 2020-2034
    • 10.6.1. U.S.
    • 10.6.2. Canada
  • 10.7. Market Attractiveness Analysis
    • 10.7.1. By Product Type
    • 10.7.2. By Test Type
    • 10.7.3. By End-user
    • 10.7.4. By Country

11. Europe Coagulation Testing Market Analysis and Forecast

  • 11.1. Introduction
  • 11.2. Key Findings
  • 11.3. Market Value Forecast, by Product Type, 2020-2034
    • 11.3.1. Instruments
    • 11.3.2. Consumables
  • 11.4. Market Value Forecast, by Test Type, 2020-2034
    • 11.4.1. Prothrombin Time (PT)
    • 11.4.2. Activated Partial Thromboplastin Clotting Time (APTT)
    • 11.4.3. Thrombin Time (TT)
    • 11.4.4. Activated Clotting Time (ACT)
    • 11.4.5. Others
  • 11.5. Market Value Forecast, by End-user, 2020-2034
    • 11.5.1. Hospitals and Clinics
    • 11.5.2. Diagnostic Laboratories
    • 11.5.3. Home Care Settings
    • 11.5.4. Others
  • 11.6. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 11.6.1. Germany
    • 11.6.2. U.K.
    • 11.6.3. France
    • 11.6.4. Italy
    • 11.6.5. Spain
    • 11.6.6. Rest of Europe
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Product Type
    • 11.7.2. By Test Type
    • 11.7.3. By End-user
    • 11.7.4. By Country/Sub-region

12. Asia Pacific Coagulation Testing Market Analysis and Forecast

  • 12.1. Introduction
  • 12.2. Key Findings
  • 12.3. Market Value Forecast, by Product Type, 2020-2034
    • 12.3.1. Instruments
    • 12.3.2. Consumables
  • 12.4. Market Value Forecast, by Test Type, 2020-2034
    • 12.4.1. Prothrombin Time (PT)
    • 12.4.2. Activated Partial Thromboplastin Clotting Time (APTT)
    • 12.4.3. Thrombin Time (TT)
    • 12.4.4. Activated Clotting Time (ACT)
    • 12.4.5. Others
  • 12.5. Market Value Forecast, by End-user, 2020-2034
    • 12.5.1. Hospitals and Clinics
    • 12.5.2. Diagnostic Laboratories
    • 12.5.3. Home Care Settings
    • 12.5.4. Others
  • 12.6. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 12.6.1. China
    • 12.6.2. Japan
    • 12.6.3. India
    • 12.6.4. Australia & New Zealand
    • 12.6.5. Rest of Asia Pacific
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Product Type
    • 12.7.2. By Test Type
    • 12.7.3. By End-user
    • 12.7.4. By Country/Sub-region

13. Latin America Coagulation Testing Market Analysis and Forecast

  • 13.1. Introduction
  • 13.2. Key Findings
  • 13.3. Market Value Forecast, by Product Type, 2020-2034
    • 13.3.1. Instruments
    • 13.3.2. Consumables
  • 13.4. Market Value Forecast, by Test Type, 2020-2034
    • 13.4.1. Prothrombin Time (PT)
    • 13.4.2. Activated Partial Thromboplastin Clotting Time (APTT)
    • 13.4.3. Thrombin Time (TT)
    • 13.4.4. Activated Clotting Time (ACT)
    • 13.4.5. Others
  • 13.5. Market Value Forecast, by End-user, 2020-2034
    • 13.5.1. Hospitals and Clinics
    • 13.5.2. Diagnostic Laboratories
    • 13.5.3. Home Care Settings
    • 13.5.4. Others
  • 13.6. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 13.6.1. Brazil
    • 13.6.2. Mexico
    • 13.6.3. Rest of Latin America
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Product Type
    • 13.7.2. By Test Type
    • 13.7.3. By End-user
    • 13.7.4. By Country/Sub-region

14. Middle East & Africa Coagulation Testing Market Analysis and Forecast

  • 14.1. Introduction
  • 14.2. Key Findings
  • 14.3. Market Value Forecast, by Product Type, 2020-2034
    • 14.3.1. Instruments
    • 14.3.2. Consumables
  • 14.4. Market Value Forecast, by Test Type, 2020-2034
    • 14.4.1. Prothrombin Time (PT)
    • 14.4.2. Activated Partial Thromboplastin Clotting Time (APTT)
    • 14.4.3. Thrombin Time (TT)
    • 14.4.4. Activated Clotting Time (ACT)
    • 14.4.5. Others
  • 14.5. Market Value Forecast, by End-user, 2020-2034
    • 14.5.1. Hospitals and Clinics
    • 14.5.2. Diagnostic Laboratories
    • 14.5.3. Home Care Settings
    • 14.5.4. Others
  • 14.6. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 14.6.1. GCC Countries
    • 14.6.2. South Africa
    • 14.6.3. Rest of Middle East & Africa
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Product Type
    • 14.7.2. By Test Type
    • 14.7.3. By End-user
    • 14.7.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
  • 15.2. Market Share Analysis, by Company (2023)
  • 15.3. Company Profiles
    • 15.3.1. F. Hoffmann-La Roche Ltd.
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Product Portfolio
      • 15.3.1.3. SWOT Analysis
      • 15.3.1.4. Financial Overview
      • 15.3.1.5. Strategic Overview
    • 15.3.2. Abbott
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Product Portfolio
      • 15.3.2.3. SWOT Analysis
      • 15.3.2.4. Financial Overview
      • 15.3.2.5. Strategic Overview
    • 15.3.3. Siemens Healthineers
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Product Portfolio
      • 15.3.3.3. SWOT Analysis
      • 15.3.3.4. Financial Overview
      • 15.3.3.5. Strategic Overview
    • 15.3.4. Sysmex Corporation
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Product Portfolio
      • 15.3.4.3. SWOT Analysis
      • 15.3.4.4. Financial Overview
      • 15.3.4.5. Strategic Overview
    • 15.3.5. Universal Biosensors, Inc.
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Product Portfolio
      • 15.3.5.3. SWOT Analysis
      • 15.3.5.4. Financial Overview
      • 15.3.5.5. Strategic Overview
    • 15.3.6. HemoSonics, LLC
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Product Portfolio
      • 15.3.6.3. SWOT Analysis
      • 15.3.6.4. Financial Overview
      • 15.3.6.5. Strategic Overview
    • 15.3.7. Thermo Fisher Scientific Inc.
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Product Portfolio
      • 15.3.7.3. SWOT Analysis
      • 15.3.7.4. Financial Overview
      • 15.3.7.5. Strategic Overview
    • 15.3.8. Randox Laboratories Ltd.
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Product Portfolio
      • 15.3.8.3. SWOT Analysis
      • 15.3.8.4. Financial Overview
      • 15.3.8.5. Strategic Overview
    • 15.3.9. Horiba, Ltd.
      • 15.3.9.1. Company Overview
      • 15.3.9.2. Product Portfolio
      • 15.3.9.3. SWOT Analysis
      • 15.3.9.4. Financial Overview
      • 15.3.9.5. Strategic Overview
    • 15.3.10. Agappe Diagnostics Ltd.
      • 15.3.10.1. Company Overview
      • 15.3.10.2. Product Portfolio
      • 15.3.10.3. SWOT Analysis
      • 15.3.10.4. Financial Overview
      • 15.3.10.5. Strategic Overview
    • 15.3.11. Medtronic
      • 15.3.11.1. Company Overview
      • 15.3.11.2. Product Portfolio
      • 15.3.11.3. SWOT Analysis
      • 15.3.11.4. Financial Overview
      • 15.3.11.5. Strategic Overview
    • 15.3.12. Helena Laboratories, Inc.
      • 15.3.12.1. Company Overview
      • 15.3.12.2. Product Portfolio
      • 15.3.12.3. SWOT Analysis
      • 15.3.12.4. Financial Overview
      • 15.3.12.5. Strategic Overview